Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing.
NPJ Precis Oncol. 2023 May 18;7(1):45. doi: 10.1038/s41698-023-00379-8.
NPJ Precis Oncol. 2023.
PMID: 37202426
Free PMC article.
Associations of Multiparametric Breast MRI Features, Tumor-Infiltrating Lymphocytes, and Immune Gene Signature Scores Following a Single Dose of Trastuzumab in HER2-Positive Early-Stage Breast Cancer.
Kennedy LC, Kazerouni AS, Chau B, Biswas D, Alvarez R, Durenberger G, Dintzis SM, Stanton SE, Partridge SC, Gadi V.
Kennedy LC, et al. Among authors: durenberger g.
Cancers (Basel). 2023 Aug 30;15(17):4337. doi: 10.3390/cancers15174337.
Cancers (Basel). 2023.
PMID: 37686613
Free PMC article.
Item in Clipboard
Targeting BET Proteins BRD2 and BRD3 in Combination with PI3K-AKT Inhibition as a Therapeutic Strategy for Ovarian Clear Cell Carcinoma.
Shigeta S, Lui GYL, Shaw R, Moser R, Gurley KE, Durenberger G, Rosati R, Diaz RL, Ince TA, Swisher EM, Grandori C, Kemp CJ.
Shigeta S, et al. Among authors: durenberger g.
Mol Cancer Ther. 2021 Apr;20(4):691-703. doi: 10.1158/1535-7163.MCT-20-0809. Epub 2021 Jan 28.
Mol Cancer Ther. 2021.
PMID: 33509905
Free PMC article.
Item in Clipboard
Cite
Cite